Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Aurora Cannabis Inc. - Common Shares (NQ:ACB)

4.810 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Oct 30, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Aurora Cannabis Inc. - Common Shares

< Previous 1 2
...
23 24 25 26 27 28 29 30 31
...
52 53 Next >
Pharma Mafia Wants To Conquer Cannabis: Can You Patent A Plant? Jazz Is Trying
The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) recently published collected data on CBD safety, placing the information under its Yellow Card alert system, which lists various... 
Via Benzinga
'Cannabis Is Not Dead' Says Aurora CEO From Helm Of Largest Global Medical Marijuana Company
Last month Canadian marijuana giant, Aurora Cannabis Inc. 
Via Benzinga
The 5 Cannabis Category Performances Have Ranged From +14.5% To -2.7% YTD
The 5 categories in the cannabis sector perform quite differently from each other. 
Via Talk Markets
Cannabis Stock Movers For March 3, 2023
 
Via Benzinga
3,000 Marijuana Leaders & Investors To Attend The Biggest Cannabis Conference In The World
The world's largest gathering of high-impact decision-makers, founders and investors in cannabis is returning to Miami Beach, Florida in 2023. 
Via Benzinga
Here's the Single Best Argument for Buying Aurora Cannabis Stock Right Now
The best case for Aurora can be summed up in four words. 
Via The Motley Fool
2 Cheap Growth Stocks to Avoid for Now
Inexpensive valuations can be a trap rather than a blessing. 
Via The Motley Fool
Aurora Launches New Cannabis Cultivar Valour, Working 'Hand-In-Hand With The Veteran Community'
Aurora Cannabis Inc. (NASDAQ: ACB) (TSX:ACB) launched Valour, a new cannabis cultivar designed for veterans, by veterans. 
Via Benzinga
1 Shocking Number That Should Have Investors Thinking Twice About Pot Stocks
The returns in the cannabis industry haven't come close to living up to the hype. 
Via The Motley Fool
1 Thing Aurora Cannabis Investors Should Watch in 2023
Could an acquisition help turn things around for this beaten-down pot stock? 
Via The Motley Fool
February Momentum Report For The 5 Major Canadian Cannabis LP Stocks
The extent of direction or momentum a stock is experiencing over a specified period of time is important. 
Via Talk Markets
Only 2 Of 5 Cannabis Categories Have Advanced YTD
The 5 categories in the cannabis sector perform quite differently from each other but YTD the common trend is mostly downward. 
Via Talk Markets
4 Of 5 Largest Canadian Cannabis LPs Have More Than A 50% Likelihood Of Going Bust
None of the 5 largest Canadian LPs have a positive Net Operating Cash Flow, and most have a less than 50% chance of staying afloat. 
Via Talk Markets
Could Aurora Cannabis Stock Be Delisted?
There's a simple answer -- and a better answer. 
Via The Motley Fool
Aurora Cannabis Stock: Bear vs. Bull
Does a good quarter make this pot stock a buy? 
Via The Motley Fool
Is Aurora Cannabis a Buy?
With its strategic transformation plan wrapping up, its future is still uncertain. 
Via The Motley Fool
Aurora And MedReleaf Australia Launch New Medical Cannabis Brand - CraftPlant
Aurora Cannabis Inc. (NASDAQ: ACB) (TSX:ACB) and MedReleaf Australia launched CraftPlant, a new medical cannabis brand for patients in the Australian market. 
Via Benzinga
Bearish Sentiment Across The Cannabis Space - Check Full Movers For February 21, 2023
 
Via Benzinga
Is Aurora Cannabis Stock A Brilliant Buy Right Now?
Things for the company could be a lot worse, but they also could be a lot better. 
Via The Motley Fool
"Multi-Bagger" Portfolio Outperforming "Rags-To-Riches" Portfolio YTD By A 2-To-1 Margin
Cannabis, psychedelic and plant-based food stocks were extremely oversold in 2022. Perhaps some will bounce back with 
Via Talk Markets
Better Buy: Aurora Cannabis vs. Cresco Labs
One was once a favorite among cannabis investors, but the other is just getting started. 
Via The Motley Fool
Where Will Aurora Cannabis Be in 1 Year?
Has the company finally begun to turn things around? 
Via The Motley Fool
4 Of The 5 Largest Canadian Cannabis LPs Are Still Up YTD
We track the performance of the 5 largest Canadian seed-to-sale licensed producers. 
Via Talk Markets
Marijuana Stock Movers For February 16, 2023
 
Via Benzinga
Aurora Cannabis Prepares For Global Legalization Wave, Analyst's Thoughts Post Q2 Earnings
Aurora Cannabis Inc. (NASDAQ: ACB) reported its financial and operational results for the fiscal second quarter that ended December 31 last week, revealing that it has 
Via Benzinga
Cannabis Stock Movers For February 15, 2023
 
Via Benzinga
Elon Musk Takes Twitter To Another Level: Greenlights Paid Ads For Cannabis & THC Products In US
The second richest man on the planet, Elon Musk, is making significant changes on the popular social media platform he recently acquired – Twitter, now allowing ads for CBD and THC products. What... 
Via Benzinga
Global Cannabis Market Revenue Is Expected To Reach $76 Billion By 2027
Palm Beach, FL – February 15, 2023 – FinancialNewsMedia.com News Commentary – The cannabis business is one of those atypical industries that actually flourished because of the pandemic. The global... 
Via FinancialNewsMedia
Topics Cannabis Economy
Cannabis Portfolio Contest Update: YTD Performances Range From +12.7% To -10.0%
An analysis of 9 portfolios, including 2 ETFs, that are competing for the distinction of being the top performing cannabis portfolio in 2023. 
Via Talk Markets
5 Cannabis-Related Categories This Week: -0.2% To -13.6%
The 5 categories in the cannabis sector perform quite differently from each other on a weekly basis and below is a summary of how each category performed the week ending February 10th, in descending... 
Via Talk Markets
< Previous 1 2
...
23 24 25 26 27 28 29 30 31
...
52 53 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.